These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 31787695)

  • 81. Vaccine effectiveness against influenza A(H3N2) and B among laboratory-confirmed, hospitalised older adults, Europe, 2017-18: A season of B lineage mismatched to the trivalent vaccine.
    Rose AMC; Kissling E; Gherasim A; Casado I; Bella A; Launay O; Lazăr M; Marbus S; Kuliese M; Syrjänen R; Machado A; Kurečić Filipović S; Larrauri A; Castilla J; Alfonsi V; Galtier F; Ivanciuc A; Meijer A; Mickiene A; Ikonen N; Gómez V; Lovrić Makarić Z; Moren A; Valenciano M;
    Influenza Other Respir Viruses; 2020 May; 14(3):302-310. PubMed ID: 32022450
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Interim 2022/23 influenza vaccine effectiveness: six European studies, October 2022 to January 2023.
    Kissling E; Maurel M; Emborg HD; Whitaker H; McMenamin J; Howard J; Trebbien R; Watson C; Findlay B; Pozo F; Bolt Botnen A; Harvey C; Rose A; ;
    Euro Surveill; 2023 May; 28(21):. PubMed ID: 37227299
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Moderate influenza vaccine effectiveness with variable effectiveness by match between circulating and vaccine strains in Australian adults aged 20-64 years, 2007-2011.
    Kelly HA; Sullivan SG; Grant KA; Fielding JE
    Influenza Other Respir Viruses; 2013 Sep; 7(5):729-37. PubMed ID: 23078073
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Seasonal Influenza Vaccine Effectiveness in Preventing Laboratory-Confirmed Influenza in Primary Care in Israel, 2016-2017 Season: Insights Into Novel Age-Specific Analysis.
    Stein Y; Mandelboim M; Sefty H; Pando R; Mendelson E; Shohat T; Glatman-Freedman A;
    Clin Infect Dis; 2018 Apr; 66(9):1383-1391. PubMed ID: 29145568
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Interim Estimates of 2017-18 Seasonal Influenza Vaccine Effectiveness - United States, February 2018.
    Flannery B; Chung JR; Belongia EA; McLean HQ; Gaglani M; Murthy K; Zimmerman RK; Nowalk MP; Jackson ML; Jackson LA; Monto AS; Martin ET; Foust A; Sessions W; Berman L; Barnes JR; Spencer S; Fry AM
    MMWR Morb Mortal Wkly Rep; 2018 Feb; 67(6):180-185. PubMed ID: 29447141
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Effectiveness of live attenuated influenza vaccine and inactivated influenza vaccine in children during the 2014-2015 season.
    McLean HQ; Caspard H; Griffin MR; Poehling KA; Gaglani M; Belongia EA; Talbot HK; Peters TR; Murthy K; Ambrose CS
    Vaccine; 2017 May; 35(20):2685-2693. PubMed ID: 28408121
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Effectiveness of the current and prior influenza vaccinations in Northern Spain, 2018-2019.
    Castilla J; Portillo ME; Casado I; Pozo F; Navascués A; Adelantado M; Gómez Ibáñez C; Ezpeleta C; Martínez-Baz I;
    Vaccine; 2020 Feb; 38(8):1925-1932. PubMed ID: 31982263
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Effect of Statin Use on Influenza Vaccine Effectiveness.
    McLean HQ; Chow BD; VanWormer JJ; King JP; Belongia EA
    J Infect Dis; 2016 Oct; 214(8):1150-8. PubMed ID: 27471318
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Interim estimates of 2019/20 vaccine effectiveness during early-season co-circulation of influenza A and B viruses, Canada, February 2020.
    Skowronski DM; Zou M; Sabaiduc S; Murti M; Olsha R; Dickinson JA; Gubbay JB; Croxen MA; Charest H; Jassem A; Krajden M; Bastien N; Li Y; De Serres G
    Euro Surveill; 2020 Feb; 25(7):. PubMed ID: 32098644
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Duration of Influenza Vaccine Effectiveness: A Systematic Review, Meta-analysis, and Meta-regression of Test-Negative Design Case-Control Studies.
    Young B; Sadarangani S; Jiang L; Wilder-Smith A; Chen MI
    J Infect Dis; 2018 Feb; 217(5):731-741. PubMed ID: 29220496
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Early estimates of seasonal influenza vaccine effectiveness in Europe: results from the I-MOVE multicentre case-control study, 2012/13.
    Valenciano M; Kissling E;
    Euro Surveill; 2013 Feb; 18(7):3. PubMed ID: 23449183
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Influenza vaccine effectiveness against laboratory confirmed influenza in Greece during the 2013-2014 season: a test-negative study.
    Lytras T; Kossyvakis A; Melidou A; Exindari M; Gioula G; Pogka V; Malisiovas N; Mentis A
    Vaccine; 2015 Jan; 33(2):367-73. PubMed ID: 25448097
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Vaccine Effectiveness Against Acute Respiratory Illness Hospitalizations for Influenza-Associated Pneumonia During the 2015-2016 to 2017-2018 Seasons: US Hospitalized Adult Influenza Vaccine Effectiveness Network (HAIVEN).
    Ghamande S; Shaver C; Murthy K; Raiyani C; White HD; Lat T; Arroliga AC; Wyatt D; Talbot HK; Martin ET; Monto AS; Zimmerman RK; Middleton DB; Silveira FP; Ferdinands JM; Patel MM; Gaglani M
    Clin Infect Dis; 2022 Apr; 74(8):1329-1337. PubMed ID: 34320171
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Evaluating the effectiveness of the influenza vaccine during respiratory outbreaks in Singapore's long term care facilities, 2017.
    Ng Y; Nandar K; Chua LAV; Mak TM; Foo K; Muhammad IR; Low CKK; Ma S; Ooi SP; Lin RTP; James L; Lee VJM
    Vaccine; 2019 Jun; 37(29):3925-3931. PubMed ID: 31160102
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Interim 2023/2024 Season Influenza Vaccine Effectiveness in Primary and Secondary Care in the United Kingdom.
    Whitaker H; Findlay B; Zitha J; Goudie R; Hassell K; Evans J; Kalapotharakou P; Agrawal U; Kele B; Hamilton M; Moore C; Byford R; Stowe J; Robertson C; Couzens A; Jamie G; Hoschler K; Pheasant K; Button E; Quinot C; Jones T; Anand S; Watson C; Andrews N; de Lusignan S; Zambon M; Williams C; Cottrell S; Marsh K; McMenamin J; Lopez Bernal J
    Influenza Other Respir Viruses; 2024 May; 18(5):e13284. PubMed ID: 38773753
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Genetic characterization of influenza viruses from influenza-related hospital admissions in the St. Petersburg and Valencia sites of the Global Influenza Hospital Surveillance Network during the 2013/14 influenza season.
    López-Labrador FX; Natividad-Sancho A; Pisareva M; Komissarov A; Salvatierra K; Fadeev A; Moya A; Grudinin M; Díez-Domingo J; Afanasieva O; Konovalova N; Sominina A; Puig-Barberà J
    J Clin Virol; 2016 Nov; 84():32-38. PubMed ID: 27690141
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Viral Shedding in Recipients of Live Attenuated Influenza Vaccine in the 2016-2017 and 2017-2018 Influenza Seasons in the United Kingdom.
    Jackson D; Pitcher M; Hudson C; Andrews N; Southern J; Ellis J; Höschler K; Pebody R; Turner PJ; Miller E; Zambon M
    Clin Infect Dis; 2020 Jun; 70(12):2505-2513. PubMed ID: 31642899
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Repeated seasonal influenza vaccination among elderly in Europe: Effects on laboratory confirmed hospitalised influenza.
    Rondy M; Launay O; Castilla J; Costanzo S; Puig-Barberà J; Gefenaite G; Larrauri A; Rizzo C; Pitigoi D; Syrjänen RK; Machado A; Kurečić Filipović S; Krisztina Horváth J; Paradowska-Stankiewicz I; Marbus S; ; Moren A
    Vaccine; 2017 Aug; 35(34):4298-4306. PubMed ID: 28709555
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Differential Influence of Age on the Relationship between Genetic Mismatch and A(H1N1)pdm09 Vaccine Effectiveness.
    Cao L; Zhao S; Lou J; Zheng H; Chan RWY; Chong MKC; Chen Z; Chan PKS; Zee BCY; Wang MH
    Viruses; 2021 Apr; 13(4):. PubMed ID: 33916601
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Effectiveness of quadrivalent influenza vaccine based on the test-negative control study in children during the 2016-2017 season.
    Ando S
    J Infect Chemother; 2018 Oct; 24(10):782-788. PubMed ID: 29945763
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.